Search Results

Renalytix AI and Kidney Disease Diagnostics

People often confuse “invest in what you know” with “invest in domestic stocks only.” Index provider MSCI builds an all-encompassing global index called the “MSCI ACWI IMI AC Index.” Forget about what all those cryptic acronyms mean, all you need to know is that 99% of all stocks around the globe from 49 countries are […]

Investing in Nanotechnology Stocks and Companies

Top Gun was the highest grossing film of the year, “Rock Me Amadeus” by Falco was the #1 single of the year, Cosby Show was the top television show, and the Chicago Bears won the Superbowl. It was 1986, the same year a much lesser known event took place. An American engineer named Eric Drexler […]

Investing in Synthetic Biology Stocks and Companies

Saint Steve Jobs once said “I think the biggest innovations of the twenty-first century will be the intersection of biology and technology.” That’s a great way to describe synthetic biology, perhaps the most disruptive technology mankind will ever create. Since all living things have DNA in their cells, we can do unimaginable things if we can: Read the DNA […]

A Guide to Investing in Gene Editing Stocks

If we had to pick one disruptive technology that has the most potential to change mankind, it would be synthetic biology (synbio). A critical component of synbio is gene editing. You cannot have one without the other. When many people first hear about the potential of gene editing, they want to invest in it. The […]

Ultrasound Technology for 5 Types of Medical Conditions

Aside from destroying the social fabric of our society, Facebook has enabled a whole generation of parents to post endless photos of their little rug rats doing all sorts of nauseatingly cute things. New parents are probably the worst, celebrating the life of their child every few weeks, as if we still lived in the […]

ArcherDX Promises Precision Oncology For All

Trying to monitor what’s happening in the disruptive technology space is a difficult task. We try to keep tabs on any IPO which dabbles in any of the 60 disruptive technology themes we research here at Nanalyze. Usually, we’ll have come across a company prior to their IPO announcement. Last May, we saw that ArcherDX […]

Mesoblast Stock Soars on Promise of Cellular Medicine

Longevity is potentially a trillion-dollar industry – until it isn’t, because we can’t keep the vulnerable safe from the latest pandemic. The Woohoo Flu has us distracted from the longevity thesis for a bit as the medical community scrambles to deal with something we can’t control. A lack of information and a fractured population means […]

The Lantern Pharma IPO Raises Some Questions

We recently published a report on seven AI healthcare stocks noting that six were the result of recent IPOs. Of those, two are involved in drug discovery. We’ve written extensively about how machine learning and computational chemistry are speeding up the drug development process and decreasing the likelihood that drugs will fail. It’s all about […]

How Berkeley Lights Enables Synthetic Biology

The human body is such an incredibly complex system that in order to truly understand it, we’ll need to emulate it by creating a digital twin. Last summer, we met with a Hungarian startup called Turbine that’s building digital cells that are so accurate they can mimic wet lab experiments. The next step is to […]

A Nano 3D Printer That Prints Nano-Sized Objects

In a recent article, we wrote about an Israeli 3D printing startup that’s developing their flagship machine “capable of micron-resolution printing, with the capability to print thousands of parts in a single build.” The ability to 3D print objects at a micro or nanoscale opens doors for many new applications. Today, we’re going to look […]